Cargando…
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287605/ https://www.ncbi.nlm.nih.gov/pubmed/28325754 http://dx.doi.org/10.1136/bmj.j1462 |
Ejemplares similares
Ejemplares similares
-
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial
por: Ormerod, Anthony D, et al.
Publicado: (2015) -
Ciclosporin compared with prednisolone therapy for patients with pyoderma gangrenosum: cost‐effectiveness analysis of the STOP GAP trial
por: Mason, J.M., et al.
Publicado: (2017) -
UK Dermatology Clinical Trials Network’s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial
por: Craig, Fiona F, et al.
Publicado: (2012) -
Pyoderma gangrenosum controlled with rituximab
por: DaCunha, Matthew, et al.
Publicado: (2019) -
Comparison of Clinical Features between Pyoderma Gangrenosum Concomitant by Inflammatory Bowel Disease and Idiopathic Pyoderma Gangrenosum
por: Jiang, Yan-Yun, et al.
Publicado: (2017)